Phoenix Biotech Acquisition Corp. Class A (PBAX)
NASDAQ:PBAX
US Market
Holding PBAX?
Track your performance easily

Phoenix Biotech Acquisition Corp. Class A (PBAX) Income Statement

8 Followers

Phoenix Biotech Acquisition Corp. Class A Income Statement

Last quarter (Q ), Phoenix Biotech Acquisition Corp. Class A's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Phoenix Biotech Acquisition Corp. Class A's net income was $-262.68K. See Phoenix Biotech Acquisition Corp. Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21
Total Revenue
-$ 0.00$ 0.00
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 2.91M$ 2.91M$ 332.03K
Operating Income
$ -2.91M$ -2.91M$ -332.03K
Net Non Operating Interest Income Expense
$ 357.58K--
Other Income Expense
$ 2.84M$ 2.84M$ -385.00
Pretax Income
$ -68.58K$ -68.58K$ -332.42K
Tax Provision
$ 599.16K$ 599.16K$ -16.87K
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -667.74K$ -667.74K$ -315.55K
Basic EPS
$ -0.03$ -0.03$ -0.03
Diluted EPS
$ -0.03$ -0.03$ -0.03
Basic Average Shares
$ 89.97M$ 22.49M$ 9.65M
Diluted Average Shares
$ 89.97M$ 22.49M$ 9.65M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 2.91M$ 2.91M$ 332.03K
Net Income From Continuing And Discontinued Operation
$ -667.74K$ -667.74K$ -315.55K
Normalized Income
$ -2.47M$ -2.37M$ -315.18K
Interest Expense
---
EBIT
$ -2.91M$ -2.91M$ -332.03K
EBITDA
$ -2.91M$ -2.91M$ -332.03K
Currency in USD

Phoenix Biotech Acquisition Corp. Class A Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis